PREVALENCE OF ANTIBODIES TO THE HAWAII STRAIN OF HUMAN CALICIVIRUS ASMEASURED BY A RECOMBINANT PROTEIN-BASED IMMUNOASSAY

Citation
Wd. Cubitt et al., PREVALENCE OF ANTIBODIES TO THE HAWAII STRAIN OF HUMAN CALICIVIRUS ASMEASURED BY A RECOMBINANT PROTEIN-BASED IMMUNOASSAY, Journal of medical virology, 54(2), 1998, pp. 135-139
Citations number
24
Categorie Soggetti
Virology
Journal title
ISSN journal
01466615
Volume
54
Issue
2
Year of publication
1998
Pages
135 - 139
Database
ISI
SICI code
0146-6615(1998)54:2<135:POATTH>2.0.ZU;2-7
Abstract
The evaluation of an enzyme immunoassay using recombinant Hawaii virus -like particles (rHVLPs) with a panel of sera which had been screened previously for antibodies to Norwalk virus (NV) and Mexico virus (MxV) is described. The assay was also applied to study the epidemiology of Hawaii virus. Adult volunteers challenged with the prototype (genogro up II, human calicivirus) HV developed significant IgG responses (16-3 2 fold rises) following challenge whereas adults challenged or natural ly infected with NV (genogroup I) did not. Lesser antibody responses ( 4-8 fold rises) were demonstrated in volunteers challenged with Snow M ountain agent (SMA) and patients infected by SRSV 'UK3' and 'UK4' stra ins, indicating a degree of antigenic relatedness among viruses within genogroup II. Comparison of the seroprevalence of Ig G antibodies to rHV, rMxV and rNV in 338 children in London showed that infections wit h genogroup II viruses are prevalent and occur earlier in life than NV . Many young children had antibodies to MxV but not HV indicating that genogroup II viruses have both conserved and antigenically distinct e pitopes. A serological study on 566 Canadians aged between 9 and 79 ye ars showed that the prevalence of antibodies to rHV rose with age from 65-100% and from 53-100% for NV. Measurement of antibody response in a heart transplant patient infected with an MxV-like virus showed sign ificant responses to both rMxV and rHV. Continuous monitoring of the p atient over two years showed that antibody levels declined rapidly to prechallenge levels after a year. (C) 1998 Wiley-Liss, Inc.